Fangzhou Inc. and Youcare Pharmaceutical Group Form Strategic AI Chronic Care Alliance

Reuters
Feb 28
Fangzhou Inc. and Youcare Pharmaceutical Group Form Strategic AI Chronic Care Alliance

Fangzhou Inc. has signed a strategic collaboration agreement with Youcare Pharmaceutical Group to advance AI-driven chronic disease services in China. The partners will co-develop digitally enabled chronic care management systems combining Youcare’s pharmaceutical expertise with Fangzhou’s AI healthcare platform, and expand full-lifecycle health management services across areas including cardiovascular, infectious and endocrine diseases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fangzhou Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602280212PRIMZONEFULLFEED9663352) on February 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10